SternAegis

DermaSensor, Inc. develops a hand-held device that uses artificial intelligence to evaluate skin lesions for cancer. It offers DermaSensor, a device that allows physicians and consumers to perform skin checks in physician offices and patient homes. The company’s device is also used for lesion identification, scanning, photon scattering, and algorithmic analysis. DermaSensor, Inc. was founded in 2009 and is based in Miami, Florida.

Zoom is India's first 100% self-drive focused car rental company (no chauffeurs). Zoom is a membership-based service that allows individuals to rent vehicles by the hour or by the day. The service is modeled after the hyper-local distribution and high-tech self-serve model used by Zipcar in the US. The Company commenced operations in February 2013. It currently operates in Bangalore, Pune, Mumbai, Chennai, Hyderabad, Delhi NCR, Kolkata, Chandigarh, Ahmedabad, Vizag, Jaipur, and Mysore.

Psudo manufactures sneakers that are locally sourced and built with recycled materials. It also provides antimicrobial, anatomically foot support for all-day wear, enabling customers to get a range of sustainable footwear. The company was founded in 2021 and is based in Saint Louis, Missouri.

Hydrobuilder.com offers a large selection of indoor grow lights, complete hydroponic system, plant nutrients, ventilation systems, grow tents and more! Hydrobuilder supplies both hobby and commercial cultivators in all 50 states.

Outstanding Foods is a plant-based foods company that likes to keep it real. Every product contains pure, wholesome ingredients meticulously prepared by renowned vegetarian Chef Dave Anderson’s proprietary culinary methods. With Outstanding Foods’ plant-based bacon chips, Pig Out, already available, along with a slew of plant-based bacon products to follow that contain absolutely nothing from animals or artificial, bacon lovers can now bacon products that are so full of flavor, and so free of guilt. Share in the overwhelming delectability at www.outstandingfoods.com.

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.

GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

PROLOR Biotech is developing proprietary versions of already-approved therapeutic proteins. The Company’s Carboxyl Terminal Peptide technology can be attached to an array of existing therapeutic proteins, stabilizing the therapy in the bloodstream and extending its lifespan without additional toxicity or loss of desired biological activity. PROLOR products under development include Human Growth Hormone (“hGH”) for the long-term treatment of children and adults with growth failure due to inadequate secretion of endogenous growth hormone (a $3 billion market opportunity). PROLOR’s hGH could potentially be injected once a week or twice per month instead of daily. PROLOR’s hGH is scheduled for Phase III trials in 2013.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

Outstanding Foods is a plant-based foods company that likes to keep it real. Every product contains pure, wholesome ingredients meticulously prepared by renowned vegetarian Chef Dave Anderson’s proprietary culinary methods. With Outstanding Foods’ plant-based bacon chips, Pig Out, already available, along with a slew of plant-based bacon products to follow that contain absolutely nothing from animals or artificial, bacon lovers can now bacon products that are so full of flavor, and so free of guilt. Share in the overwhelming delectability at www.outstandingfoods.com.

BackBeat Medical Inc. is a medical technology company founded in 2010 to develop novel cardiac stimulation-based therapies for hypertension and heart failure. BackBeat has developed a patented cardiac pacing-based treatment for hypertension (HTN) called programmable hypertension control (PHC) therapy. PHC is comprised of proprietary pacing algorithms that can be readily incorporated into standard pacemakers using standard leads and standard lead placement and thus has broad applicability. PHC offers a new potent device-based HTN therapeutic alternative potentially opening up a large market to treat HTN patients, particularly HTN patients who already have or require a pacemaker. Clinical results generated to date using BackBeat’s own Moderato™ pacemaker incorporating PHC algorithms demonstrate that this therapy has a substantial and sustained therapeutic effect on blood pressure as determined by both in-office cuff measurements (average reduction of 24 mmHg from baseline) and 24-hour ambulatory measurements (average reduction of 14 mmHg from Baseline) with clinical follow up extending past two years in certain patients. BackBeat's PHC therapy is protected by an extensive global patent portfolio.

Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

Outstanding Foods is a plant-based foods company that likes to keep it real. Every product contains pure, wholesome ingredients meticulously prepared by renowned vegetarian Chef Dave Anderson’s proprietary culinary methods. With Outstanding Foods’ plant-based bacon chips, Pig Out, already available, along with a slew of plant-based bacon products to follow that contain absolutely nothing from animals or artificial, bacon lovers can now bacon products that are so full of flavor, and so free of guilt. Share in the overwhelming delectability at www.outstandingfoods.com.

Adgero Biopharmaceuticals Holdings, Inc. is a privately-held biopharmaceutical company focused on building a pipeline by advancing its proprietary late stage photodynamic therapy ("PDT"​) platform with broad utility for the treatment of serious oncology indications. Its lead product candidate, REM-001 Therapy, has demonstrated promising safety and efficacy in four Phase 2/3 clinical studies in patients with cutaneous metastatic breast cancer ("CMBC"​) who have failed radiation therapy. Use of Adgero's existing data or the completion of a Phase 3 trial in individuals with CMBC could lead to approval of REM-001 Therapy.

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.

Kintara Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The company’s principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. Kintara Pharmaceuticals, Inc. also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. The company was founded in 2010 and is headquartered in Vancouver, Canada.

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The company is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for the implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Super League Gaming, Inc. operates an amateur esports content network. The company engages in capturing, generating, aggregating, and distributing content in various esports through social media, live streaming, and video-on-demand, as well as continuous gameplay and leaderboards. It offers Framerate, an independent social video esports network with user-generated reels; and Minehut, a social and gameplay forum for the avid Minecraft community. The company was formerly known as Nth Games, Inc. and changed its name to Super League Gaming, Inc. in June 2015. Super League Gaming, Inc. was incorporated in 2014 and is based in Santa Monica, California.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.

Clover Inc. develops a mobile-based dating and chat application for online daters. Its application enables users to meet people who want to meet them; browse people in their area or choose destinations from around the world; get matched with singles based on type of person, location, and time, as well as find information about popular places to take a first date; and confirm the place and time to setup a date. The company was founded in 2014 and is based in Toronto, Canada.

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.

Adgero Biopharmaceuticals Holdings, Inc. is a privately-held biopharmaceutical company focused on building a pipeline by advancing its proprietary late stage photodynamic therapy ("PDT"​) platform with broad utility for the treatment of serious oncology indications. Its lead product candidate, REM-001 Therapy, has demonstrated promising safety and efficacy in four Phase 2/3 clinical studies in patients with cutaneous metastatic breast cancer ("CMBC"​) who have failed radiation therapy. Use of Adgero's existing data or the completion of a Phase 3 trial in individuals with CMBC could lead to approval of REM-001 Therapy.

Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics (genomics, transcriptomics, metabolomics) analysis to develop drugs across a range of therapeutic areas, with an initial focus in non-alcoholic steatohepatitis (NASH,“fatty liver disease”). Founded and staffed by a team composed of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is driving a revolution in drug discovery, overthrowing the old paradigm of discovery in animal models.

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

Deem is a technology platform for the business travel industry focusing on travel, car service, and expense solutions. Its mission is to make business travel less complicated for travelers, less costly for employers, and more profitable for service providers. Using its industry-leading software solutions, employees book travel and car service and report those expenses faster and more easily than ever before. Corporations control costs more effectively. Travel management companies deliver more engaging customer experiences. Car service operators benefit from new efficiencies and widen their customer reach. The company was founded in 1999 and headquartered in San Francisco, California.

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections. The company develops orally delivered therapeutics based on a proprietary, lipid crystal drug delivery platform called cochleate delivery technology. Its lead product candidate is MAT 2203, an oral formulation of the broad spectrum anti-fungal drug amphotericin B that is in Phase II study for the treatment of fungal infections. The company is also involved in developing MAT2501, an orally-administered, encochleated formulation of amikacin for acute bacterial infections, including non-tuberculous mycobacterium (NTM) and multi-drug resistant gram negative bacterial infections. In addition, it is exploring development and partnership options for MAT9001, a prescription-only omega-3 fatty acid-based composition under development for hypertriglyceridemia; and MAT8800 discovery program, which intends to identify product candidates derived from omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. Matinas BioPharma Holdings, Inc. was incorporated in 2013 and is based in Bedminster, New Jersey.

Caliber Therapeutics, Inc. engages in the development and commercialization of minimally-invasive balloon-based drug delivery products for the intervention of atherosclerotic diseases. It offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. Caliber Therapeutics, Inc. is based in Monmouth Junction, New Jersey.

Zoom is India's first 100% self-drive focused car rental company (no chauffeurs). Zoom is a membership-based service that allows individuals to rent vehicles by the hour or by the day. The service is modeled after the hyper-local distribution and high-tech self-serve model used by Zipcar in the US. The Company commenced operations in February 2013. It currently operates in Bangalore, Pune, Mumbai, Chennai, Hyderabad, Delhi NCR, Kolkata, Chandigarh, Ahmedabad, Vizag, Jaipur, and Mysore.

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.

Kintara Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The company’s principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. Kintara Pharmaceuticals, Inc. also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. The company was founded in 2010 and is headquartered in Vancouver, Canada.

Hydrofarm is one of the nation’s leading wholesalers and manufacturers of hydroponics equipment and horticultural products, including high intensity grow lights, climate control solutions and growing media. With more than 39 years in business, the Company is committed to being the number one wholesaler of horticultural products. Hydrofarm has seven nationwide distribution centers across the country to best serve its customers on a national scale.

Outstanding Foods is a plant-based foods company that likes to keep it real. Every product contains pure, wholesome ingredients meticulously prepared by renowned vegetarian Chef Dave Anderson’s proprietary culinary methods. With Outstanding Foods’ plant-based bacon chips, Pig Out, already available, along with a slew of plant-based bacon products to follow that contain absolutely nothing from animals or artificial, bacon lovers can now bacon products that are so full of flavor, and so free of guilt. Share in the overwhelming delectability at www.outstandingfoods.com.

Helocyte Inc. (“Helocyte”), a portfolio company of Fortress Biotech, is focused on the development and commercialization of novel immunotherapies for the prevention and treatment of cytomegalovirus (“CMV”). We aim to: (1) secure rights to new technologies via acquisition, licensing, co-development and/or other partnering; (2) fund research and development of new technologies; and (3) ultimately introduce new technologies to market. We are currently progressing three immunotherapies developed in the laboratory of Donald J. Diamond Ph.D., Chair of the Department of Experimental Therapeutics at City of Hope of Duarte, California (“City of Hope”). In March of 2015, Helocyte consummated an exclusive worldwide license and option agreement with City of Hope, acquiring rights to the current Helocyte programs. PepVax, is an HLA-restricted single antigen [UL83 (pp65)] peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant (“HSCT”) recipients. In July of 2015, we opened a Phase 2 study of PepVax in allogeneic HSCT recipients. Our second program, Triplex, is a universal (non-HLA-restricted) recombinant viral vector vaccine expressing three immuno-dominant proteins [UL83 (pp65), UL123 (IE1), UL122 (IE2)] linked to CMV in the post-transplant setting. In November of 2015, we opened a Phase 2 study of Triplex in allogeneic HSCT recipients. We additionally plan to study Triplex in recipients of allogeneic Solid Organ Transplantation. Our third program, Pentamer, is a universal (non-HLA-restricted) recombinant viral vector vaccine expressing five primary subunits of CMV (gH/gL/UL128/UL130/UL131A) linked to viral transmission in utero. The Pentamer program is currently undergoing nonclinical development and will ultimately be studied for prevention of congenital CMV.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

Corbus Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of inflammatory fibrotic diseases. Its product includes Resunab, an orally bioavailable synthetic CB2 agonist. The company was founded in 2014 and is based in Norwood, Massachusetts. Corbus Pharmaceuticals, Inc. operates as a subsidiary of Corbus Pharmaceuticals Holdings, Inc.

Armada Water Assets provides water supply, collection, and remediation services. Armada is a fully integrated service company dedicated to the safe and cost-effective collection, handling, transport, treatment, and reuse of contaminated water produced by conventional oil and gas production (produced water) and hydraulic-fracturing flow-back water. It was founded in 2012 and headquartered in Houston, Texas.

Zoom is India's first 100% self-drive focused car rental company (no chauffeurs). Zoom is a membership-based service that allows individuals to rent vehicles by the hour or by the day. The service is modeled after the hyper-local distribution and high-tech self-serve model used by Zipcar in the US. The Company commenced operations in February 2013. It currently operates in Bangalore, Pune, Mumbai, Chennai, Hyderabad, Delhi NCR, Kolkata, Chandigarh, Ahmedabad, Vizag, Jaipur, and Mysore.